Literature DB >> 19225002

The marburg virus 3' noncoding region structurally and functionally differs from that of ebola virus.

Sven Enterlein1, Kristina M Schmidt, Michael Schümann, Dominik Conrad, Verena Krähling, Judith Olejnik, Elke Mühlberger.   

Abstract

We have previously shown that the first transcription start signal (TSS) of Zaire Ebola virus (ZEBOV) is involved in formation of an RNA secondary structure regulating VP30-dependent transcription activation. Interestingly, transcription of Marburg virus (MARV) minigenomes occurs independently of VP30. In this study, we analyzed the structure of the MARV 3' noncoding region and its influence on VP30 necessity. Secondary structure formation of the TSS of the first gene was experimentally determined and showed substantial differences from the structure formed by the ZEBOV TSS. Chimeric MARV minigenomes mimicking the ZEBOV-specific RNA secondary structure were neither transcribed nor replicated. Mapping of the MARV genomic replication promoter revealed that the region homologous to the sequence involved in formation of the regulatory ZEBOV RNA structure is part of the MARV promoter. The MARV promoter is contained within the first 70 nucleotides of the genome and consists of two elements separated by a spacer region, comprising the TSS of the first gene. Mutations within the spacer abolished transcription activity and led to increased replication, indicating competitive transcription and replication initiation. The second promoter element is located within the nontranslated region of the first gene and consists of a stretch of three UN(5) hexamers. Recombinant full-length MARV clones, in which the three conserved U residues were substituted, could not be rescued, underlining the importance of the UN(5) hexamers for replication activity. Our data suggest that differences in the structure of the genomic replication promoters might account for the different transcription strategies of Marburg and Ebola viruses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19225002      PMCID: PMC2668471          DOI: 10.1128/JVI.02429-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Nature of a paramyxovirus replication promoter influences a nearby transcription signal.

Authors:  Diane Vulliémoz; Samuel Cordey; Geneviève Mottet-Osman; Laurent Roux
Journal:  J Gen Virol       Date:  2005-01       Impact factor: 3.891

2.  Inhibition of Marburg virus protein expression and viral release by RNA interference.

Authors:  Trent Fowler; Sandra Bamberg; Peggy Möller; Hans-Dieter Klenk; Thomas F Meyer; Stephan Becker; Thomas Rudel
Journal:  J Gen Virol       Date:  2005-04       Impact factor: 3.891

3.  Identification of internal sequences in the 3' leader region of human respiratory syncytial virus that enhance transcription and confer replication processivity.

Authors:  David R McGivern; Peter L Collins; Rachel Fearns
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

4.  Three of the four nucleocapsid proteins of Marburg virus, NP, VP35, and L, are sufficient to mediate replication and transcription of Marburg virus-specific monocistronic minigenomes.

Authors:  E Mühlberger; B Lötfering; H D Klenk; S Becker
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

5.  Promoter elements in the influenza vRNA terminal structure.

Authors:  R Flick; G Neumann; E Hoffmann; E Neumeier; G Hobom
Journal:  RNA       Date:  1996-10       Impact factor: 4.942

6.  The activity of Sendai virus genomic and antigenomic promoters requires a second element past the leader template regions: a motif (GNNNNN)3 is essential for replication.

Authors:  C Tapparel; D Maurice; L Roux
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

7.  RNA polymerase I-driven minigenome system for Ebola viruses.

Authors:  Allison Groseth; Heinz Feldmann; Steven Theriault; Gülsah Mehmetoglu; Ramon Flick
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

8.  Minimum protein requirements for transcription and RNA replication of a minigenome of human parainfluenza virus type 3 and evaluation of the rule of six.

Authors:  A P Durbin; J W Siew; B R Murphy; P L Collins
Journal:  Virology       Date:  1997-07-21       Impact factor: 3.616

9.  Ebola virus defective interfering particles and persistent infection.

Authors:  P Calain; M C Monroe; S T Nichol
Journal:  Virology       Date:  1999-09-15       Impact factor: 3.616

10.  Mapping of the RNA promoter of Newcastle disease virus.

Authors:  Fernando Marcos; Laura Ferreira; Jerome Cros; Man-Seong Park; Takaaki Nakaya; Adolfo García-Sastre; Enrique Villar
Journal:  Virology       Date:  2005-01-20       Impact factor: 3.616

View more
  15 in total

1.  Recombinant Marburg virus expressing EGFP allows rapid screening of virus growth and real-time visualization of virus spread.

Authors:  Kristina Maria Schmidt; Michael Schümann; Judith Olejnik; Verena Krähling; Elke Mühlberger
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

2.  Ebola virus VP35 antagonizes PKR activity through its C-terminal interferon inhibitory domain.

Authors:  Michael Schümann; Thorsten Gantke; Elke Mühlberger
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

3.  Structural basis for Marburg virus VP35-mediated immune evasion mechanisms.

Authors:  Parameshwaran Ramanan; Megan R Edwards; Reed S Shabman; Daisy W Leung; Ariel C Endlich-Frazier; Dominika M Borek; Zbyszek Otwinowski; Gai Liu; Juyoung Huh; Christopher F Basler; Gaya K Amarasinghe
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-26       Impact factor: 11.205

4.  Analysis of the highly diverse gene borders in Ebola virus reveals a distinct mechanism of transcriptional regulation.

Authors:  Kristina Brauburger; Yannik Boehmann; Yoshimi Tsuda; Thomas Hoenen; Judith Olejnik; Michael Schümann; Hideki Ebihara; Elke Mühlberger
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

Review 5.  Minigenomes, transcription and replication competent virus-like particles and beyond: reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever viruses.

Authors:  Thomas Hoenen; Allison Groseth; Fabian de Kok-Mercado; Jens H Kuhn; Victoria Wahl-Jensen
Journal:  Antiviral Res       Date:  2011-06-14       Impact factor: 5.970

6.  Sequence variability in viral genome non-coding regions likely contribute to observed differences in viral replication amongst MARV strains.

Authors:  Jesus A Alonso; Jean L Patterson
Journal:  Virology       Date:  2013-03-16       Impact factor: 3.616

Review 7.  Distinct Genome Replication and Transcription Strategies within the Growing Filovirus Family.

Authors:  Adam J Hume; Elke Mühlberger
Journal:  J Mol Biol       Date:  2019-06-29       Impact factor: 5.469

8.  Marburg virus evades interferon responses by a mechanism distinct from ebola virus.

Authors:  Charalampos Valmas; Melanie N Grosch; Michael Schümann; Judith Olejnik; Osvaldo Martinez; Sonja M Best; Verena Krähling; Christopher F Basler; Elke Mühlberger
Journal:  PLoS Pathog       Date:  2010-01-15       Impact factor: 6.823

Review 9.  Forty-five years of Marburg virus research.

Authors:  Kristina Brauburger; Adam J Hume; Elke Mühlberger; Judith Olejnik
Journal:  Viruses       Date:  2012-10-01       Impact factor: 5.048

10.  Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA.

Authors:  Jens H Kuhn; Yīmíng Bào; Sina Bavari; Stephan Becker; Steven Bradfute; Kristina Brauburger; J Rodney Brister; Alexander A Bukreyev; Yíngyún Caì; Kartik Chandran; Robert A Davey; Olga Dolnik; John M Dye; Sven Enterlein; Jean-Paul Gonzalez; Pierre Formenty; Alexander N Freiberg; Lisa E Hensley; Thomas Hoenen; Anna N Honko; Georgy M Ignatyev; Peter B Jahrling; Karl M Johnson; Hans-Dieter Klenk; Gary Kobinger; Matthew G Lackemeyer; Eric M Leroy; Mark S Lever; Elke Mühlberger; Sergey V Netesov; Gene G Olinger; Gustavo Palacios; Jean L Patterson; Janusz T Paweska; Louise Pitt; Sheli R Radoshitzky; Elena I Ryabchikova; Erica Ollmann Saphire; Aleksandr M Shestopalov; Sophie J Smither; Nancy J Sullivan; Robert Swanepoel; Ayato Takada; Jonathan S Towner; Guido van der Groen; Viktor E Volchkov; Valentina A Volchkova; Victoria Wahl-Jensen; Travis K Warren; Kelly L Warfield; Manfred Weidmann; Stuart T Nichol
Journal:  Arch Virol       Date:  2013-11-05       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.